Cite
HARVARD Citation
Provencio, M. et al. (2019). Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years. Leukemia & lymphoma. 60 (3), pp. 856-859. [Online].